Trends in Initial Cardiac Function, Treatment, and Outcomes in Peripartum Cardiomyopathy
Journal of Obstetrics and Gynaecology Research · 2026-07 · 52 (7)
DOI: 10.1111/jog.70395 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Obstetrics and Gynaecology Research, online erschienen am 01.07.2026. Verfasst von Yusuke Kohno und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan. Hauptthemen laut MEDLINE: Peripartum Cardiomyopathy, Heart Failure, Pregnancy Complications, Cardiovascular. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Peripartum cardiomyopathy (PPCM) is a rare disease that causes heart failure during pregnancy or in the early postpartum period, and there were no reports on the trend of clinical condition and treatment in Japan. This explanatory retrospective study aimed to investigate the changes in clinical conditions and treatment in patients with PPCM.
Methods
Twenty‐three patients (aged 22–43 years; mean age, 32 years) with PPCM from four hospitals in Nagasaki Prefecture were included. We compared the heart failure status and treatments of PPCM between the 10 years from January 2002 to December 2011 (first era) ( N = 10) and the 11 years from January 2012 to December 2022 (second era) ( N = 13).
Results
Left ventricular ejection fraction (LVEF) on admission was higher (first era 20% (interquartile range (IQR) 17–34) vs. second era 34% (IQR 25–37), p = 0.0213), and less patients treated with inotropes in patients in second era than those in first era (first era 6/10 (60%) vs. second era 2/13 (15%), p = 0.0393). Hospitalization period was shorter in second era than those in first era (first era 38 days (IQR 22–45) vs. second era 19 days (IQR 16–22), p = 0.0159).
Conclusion
In recent years, patients with PPCM have been admitted before progression of LV dysfunction, and that may be related to a decrease in use of inotropes and hospitalization period in Japan.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiovascular Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
- Department of Cardiology, National Hospital Organization Nagasaki Medical Center, Omura, Nagasaki, Japan.
- Department of Obstetrics and Gynecology, National Hospital Organization Nagasaki Medical Center, Omura, Nagasaki, Japan.
- Department of Cardiology, Sasebo City General Hospital, Sasebo, Japan.
- Department of Cardiovascular Medicine, Nagasaki Harbor Medical Center, Nagasaki, Japan.
- Department of Obstetrics and Gynecology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
ORCID-Profile: Hiroaki Kawano, Kiyonori Miura
Zitieren
APA
Kohno, Y., Kawano, H., Matsuo, T., Oku, K., Suga, S., Muroya, T., Takeno, M., Hasegawa, Y., Maemura, K., & Miura, K. (2026). Trends in Initial Cardiac Function, Treatment, and Outcomes in Peripartum Cardiomyopathy. Journal of Obstetrics and Gynaecology Research, 52(7). https://doi.org/10.1111/jog.70395
Vancouver
Kohno Y, Kawano H, Matsuo T, Oku K, Suga S, Muroya T, et al. Trends in Initial Cardiac Function, Treatment, and Outcomes in Peripartum Cardiomyopathy. Journal of Obstetrics and Gynaecology Research. 2026;52(7). doi:10.1111/jog.70395
BibTeX
@article{Kohno2026,
author = {Kohno, Yusuke and Kawano, Hiroaki and Matsuo, Takashi and Oku, Koji and Suga, Sachie and Muroya, Takahiro and Takeno, Masayoshi and Hasegawa, Yuri and Maemura, Koji and Miura, Kiyonori},
title = {Trends in Initial Cardiac Function, Treatment, and Outcomes in Peripartum Cardiomyopathy},
journal = {Journal of Obstetrics and Gynaecology Research},
year = {2026},
volume = {52},
number = {7},
doi = {10.1111/jog.70395}
}
EUVIMED